A new development is emerging at the intersection of medicine and silicon valley, referred to as the longevity paradox. This involves a company called Altos Labs, which is reportedly a significant investment by silicon valley in the pursuit of longevity. The nature and goals of Altos Labs' efforts are not entirely clear, but it appears to be a notable endeavor in the field.